Rigel Pharmaceuticals Welcomes Dr. Mark W. Frohlich to its Board of Directors Rigel Pharmaceuticals has appointed Dr. Mark W. Frohlich to its Board of Directors. Dr. Frohlich brings over 25 years of unique experience in oncology.

Rigel Pharmaceuticals Welcomes Dr. Mark W. Frohlich to its Board of Directors #USA #oncology #South_San_Francisco #Rigel_Pharmaceuticals #Mark_Frohlich